European Archives - Page 347 of 1177 - European Medical Journal

ViiV's Dr Harmony Garges on making a difference in HIV

Dr Harmony Garges, talks to EMJ GOLD about her decision to join the pharmaceutical industry, treating children with HIV and her views on improving access to HIV treatment.

Oritavancin Use In Recurrent Bone Infections by Methicillin-Resistant Staphylococcus aureus

Oritavancin is a novel long-acting lipoglycopeptide that is active against gram-positive micro-organisms, including…

Review of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Congress 2024

“WE at the ESCMID continue to raise our game and lead the field to prevent, treat, and fight infections,” announced Annelies Zinkernagel,…

Latest Microbiology & Infectious Diseases Journal Out Now!

Explore this issue for an array of peer-reviewed articles, an exclusive interview with a leading global expert, and a review of ESCMID 2024!

EMJ Microbiology & Infectious Diseases 5.1 2024

In the latest issue of EMJ Microbiology & Infectious Diseases, you will find an array of peer-reviewed articles, exclusive interviews with…

Surveillance of Surgical Site Infections in Post-operative Patients and Bacterial Susceptibility

Surgical site infections (SSI) are infections occurring within 30 days of the post-operative procedure. They are common post-operative…

Implementation of Genomic Surveillance for Antimicrobial Resistance

AN ILLUMINATING session on the implementation of genomic surveillance for monitoring of antimicrobial resistance (AMR) patterns globally…

ESCMID 2024 Abstract Highlights

OVER the last 30 years, there has been a significant rise in both the number of solid organ transplant recipients, and the success rates…

Virtual Discovery of Immune-Stimulating Epitopes in Chikungunya Virus for Vaccine Design

Epitope identification is a key step in vaccine development, and this can be achieved much faster and less expensively with in silico…

The Future of Infection Treatment and Prevention in Immunocompromised Patients

THE emerging role of biological therapies in treating and preventing infection in patients who are immunocompromised was the primary focus…